Trial intelligence / Profile preview

Vitamin D3 as Neoadjuvant for PDT in Actinic Keratosis

NCT04140292Phase 2Completed

Sponsor
Case Comprehensive Cancer Center
Start
Jan 2020
Primary completion
Nov 2020
Countries
1
01

Overview

A Phase 2 trial of vitamin d in actinic keratosis (AK), sponsored by Case Comprehensive Cancer Center. Started Jan 2020; status: completed.

02

Drugs

vitamin d
03

Conditions

actinic keratosis (AK)

Beyond the preview

Go deeper on NCT04140292.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04140292.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call